Epitech
Yoqne`am `illit
About Epitech
Epitech is a developer of non-invasive ocular neurostimulation therapy, designed to treat the entire ocular surface and tear film, for long-lasting relief of dry eye symptoms. Its proprietary technology is based on neurostimulation by targeted magnetic fields, resulting in the reinforcement of the structural integrity of the ocular surface. Epitech the company was founded in 2015 and is based in Yokneam Illit, Israel.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Seed (Jan 2015)
- Website: epitechmag.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/epitech-2737950 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.